Risk factors and coping strategies of severe community-acquired pneumonia in chemotherapy induction period of acute leukemia

Li,Ning; Duan,Qingcheng; Zhang,Weidan

doi:10.3892/ol.2018.7731

Risk factors and coping strategies of severe community-acquired pneumonia in chemotherapy induction period of acute leukemia

Authors:
- Ning Li
- Qingcheng Duan
- Weidan Zhang
View Affiliations

Affiliations: Department of Hematology, Dezhou People's Hospital, Dezhou, Shandong 253014, P.R. China, Department of Emergency, Dezhou People's Hospital, Dezhou, Shandong 253014, P.R. China
Published online on: January 4, 2018 https://doi.org/10.3892/ol.2018.7731
Pages: 3566-3571
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The risk factors and coping strategies of severe community-acquired pneumonia (SCAP) in chemotherapy induction period of acute leukemia were investigated. Eighty-six patients with CAP in chemotherapy induction period of acute leukemia in Dezhou Hospital from March 2014 to February 2017 were selected and divided into observation group (SCAP group, n=45) and control group (non-SCAP group, n=41) according to the acute physiology and chronic health evolution II (APACHE II) score. The blood, sputum, nasopharyngeal secretion and pleural effusion samples were collected from patients in both groups, and the samples were detected for pathogens, followed by the analysis of relevant factors. The dynamic changes in the sequential organ failure assessment (SOFA) score, procalcitonin (PCT), D-dimer (D-D) and C-reactive protein (CRP) levels in patients were observed before and after the corresponding treatment strategies were taken. The total distribution ratio of pathogens from high to low in the two groups was as follows: bacterium, virus, fungus, mycoplasma and chlamydia trachomatis; there was no significant difference between the two groups (P>0.05). Logistic regression analysis showed that the repeated infection (OR=3.315, P=0.005), multi-resistant bacterial infection (OR=1.915, P=0.008) and D-D (OR=1.936, P=0.009) were independent risk factors for SCAP (P<0.05). After different coping strategies were taken, the SOFA score, PCT, D-D and CRP levels in the two groups were significantly decreased, and they were obviously higher in observation group than those in control group (P<0.05). Repeated infection, D-D level and multi-resistant bacterial infection are the risk factors affecting the SCAP in chemotherapy induction period of acute leukemia. The coping strategies can effectively relieve the patient's condition, reduce the severity of disease and improve the survival rate of patients.

View Figures

View References

1	Fransecky L, Mochmann LH and Baldus CD: Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Mol Cell Ther. 3:22015. View Article : Google Scholar : PubMed/NCBI
2	Annesley CE and Brown P: Novel agents for the treatment of childhood acute leukemia. Ther Adv Hematol. 6:61–79. 2015. View Article : Google Scholar : PubMed/NCBI
3	Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, et al: The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 122:2186–2196. 2016. View Article : Google Scholar : PubMed/NCBI
4	Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al CDC EPIC Study Team, : Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 373:415–427. 2015. View Article : Google Scholar : PubMed/NCBI
5	Gopakumar KG, Priyakumari T and Kusumakumary M: Infectious complications during induction chemotherapy in children with acute myeloid leukemia. Pediatr Hematol Oncol J. 1:S152016. View Article : Google Scholar
6	Avdonina MA, Abramov IS, Ammour YI and Nasedkina TV: Allelic variants of immune response genes in children with infectious complications during the treatment of acute leukemia. Mol Biol (Mosk). 51:301–307. 2017.(In Russian). View Article : Google Scholar : PubMed/NCBI
7	Saleno CH, Camacho JR, Neto LM and Mendonca RG: P-177: The Sequential Organ Failure Assessment (SOFA) score is a predictive factor for 14-day mortality of elderly patients with advanced cancer who present to the ED. Eur Geriatr Med. 2015:S79. 1959.
8	Bleakley M, Heimfeld S, Loeb KR, Jones LA, Chaney C, Seropian S, Gooley TA, Sommermeyer F, Riddell SR and Shlomchik WD: Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts. J Clin Invest. 125:2677–2689. 2015. View Article : Google Scholar : PubMed/NCBI
9	Knaus HA, Kanakry CG, Luznik L and Gojo I: Immunomodulatory drugs: Immune checkpoint agents in acute leukemia. Curr Drug Targets. 18:315–331. 2017. View Article : Google Scholar : PubMed/NCBI
10	Bigliardi S, Morselli M, Potenza L, Riva G, Coluccio V, Maccaferri M, Paolini A, Colaci E, Fantuzzi V, Soci F, et al: Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: A retrospective single center study. Ann Hematol. 94:1931–1934. 2015. View Article : Google Scholar : PubMed/NCBI
11	Shokouhi S, Tehrani S and Hemmatian M: Mixed pulmonary infection with Penicillium notatum and Pneumocystis jiroveci in a patient with acute myeloid leukemia. Tanaffos. 15:53–56. 2016.PubMed/NCBI
12	Nie W, Huang Q, Chen Y and Yin X: Treatment of an elderly patient with acute myeloid leukemia and invasive pulmonary aspergillosis infection with combined allogeneic hematopoietic stem cells microtransplantation and voriconazole. Indian J Hematol Blood Transfus. 32 Suppl 1:56–58. 2016. View Article : Google Scholar : PubMed/NCBI
13	Hakim H, Dallas R, Zhou Y, Pei D, Cheng C, Flynn PM, Pui CH and Jeha S: Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia. Cancer. 122:798–805. 2016. View Article : Google Scholar : PubMed/NCBI
14	Sadarangani M, Harvey M, McDonald A, Speert DP and Dix D: Brain abscesses due to Aspergillus nidulans infection during induction chemotherapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 37:e384–e386. 2015. View Article : Google Scholar : PubMed/NCBI
15	Kurai D, Sasaki Y, Saraya T, Ishii H, Tsukagoshi H, Kozawa K, Ryo A, Ishioka T, Kuroda M, Oishi K, et al: Pathogen profiles and molecular epidemiology of respiratory viruses in Japanese inpatients with community-acquired pneumonia. Respir Investig. 54:255–263. 2016. View Article : Google Scholar : PubMed/NCBI
16	Çolak A, Yılmaz C, Toprak B and Aktoğu S: Procalcitonin and CRP as biomarkers in discrimination of community-acquired pneumonia and exacerbation of COPD. J Med Biochem. 36:122–126. 2017. View Article : Google Scholar : PubMed/NCBI
17	Rodríguez AH, Avilés-Jurado FX, Díaz E, Schuetz P, Trefler SI, Solé-Violán J, Cordero L, Vidaur L, Estella Á, Pozo Laderas JC, et al SEMICYUC/GETGAG Working Group, : Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis. J Infect. 72:143–151. 2016. View Article : Google Scholar : PubMed/NCBI
18	Chou SC, Ko HW and Lin YC: CRP/IL-6/IL-10 Single-nucleotide polymorphisms correlate with the susceptibility and severity of community-acquired pneumonia. Genet Test Mol Biomarkers. 20:732–740. 2016. View Article : Google Scholar : PubMed/NCBI
19	Fukumoto K, Taniguchi T, Usami N, Kawaguchi K, Fukui T, Ishiguro F, Nakamura S and Yokoi K: Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer. Surg Today. 45:63–67. 2015. View Article : Google Scholar : PubMed/NCBI
20	Duarte JC, Tavares e Castro A, Silva R, Correia L, Simão A and Carvalho A: Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia: A prospective study. Rev Port Pneumol 2006. 21:218–219. 2015.PubMed/NCBI